Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study
暂无分享，去创建一个
M. Boers | O. Hoekstra | E. Smit | P. Postmus | G. Teule | E. Comans | H. Tinteren | P. Verboom | C. U. Uyl‐de Groot | R. Stallaert | E. Grijseels | A. Schreurs | the Plus study group | Jan H. A. M. Bergh | Piet C. M. Velthoven | F. W. Diepenhorst | J. Mourik | J. Bergh | P. C. V. Velthoven | Fred W. Diepenhorst